Breast Tumor Susceptibility to Chemotherapy via Support Vector Machines
| dc.contributor.author | Mangasarian, Olvi | |
| dc.contributor.author | Fung, Glenn | |
| dc.date.accessioned | 2013-01-17T17:50:40Z | |
| dc.date.available | 2013-01-17T17:50:40Z | |
| dc.date.issued | 2003 | |
| dc.description.abstract | Support vector machines (SVMs), utilizing RNA signature measurements, were used to generate a classi er to distinguish breast cancer patients that are partial-responders to chemotherapy treatment, from patients that are nonresponders. Partial responders are patients whose tumors were reduced by at least 50%. A stand-alone linear-programmingbased SVM algorithm was used to separate the partial-responders from the nonresponders. A novel aspect of the classi cation approach utilized here is that each patient is represented by multiple points (replicates) in the 25-dimensional input space of RNA signature measurements. Replicates for all patients except those for one patient, were used as a training set. The average of the replicates for the patient left out was then used to test the leave one out correctness (looc). The looc for a group of 35 patients, with 9 partial-responders and 26 nonresponders was 94.2%, in an input space of 5 RNA measurements extracted from an original space of 25 RNA measurements. | en |
| dc.identifier.citation | 03-06 | en |
| dc.identifier.uri | http://digital.library.wisc.edu/1793/64326 | |
| dc.subject | DNA macroarrays | en |
| dc.subject | chemotherapy | en |
| dc.subject | breast cancer | en |
| dc.subject | support vector machines | en |
| dc.title | Breast Tumor Susceptibility to Chemotherapy via Support Vector Machines | en |
| dc.type | Technical Report | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 03-06.pdf
- Size:
- 166.03 KB
- Format:
- Adobe Portable Document Format
- Description:
- Breast Tumor Susceptibility to Chemotherapy via Support Vector Machines
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.03 KB
- Format:
- Item-specific license agreed upon to submission
- Description: